China’s Advanced Medical Center Boao Yiling Lichang announced: “The Israeli product Regenogel is unique in China and will help 150 million Chinese fight inflammation and joint pain.”
Published yesterday morning a review about the Regenogel product distributed by SinoSciences Co., LTD in China.
The product, which was presented this week at the hospital’s annual conference, was praised by senior orthopedic specialists in China. The following is an excerpt from the article:
“According to data released by the World Health Organization, 10% of the current medical problems in the global population are due to osteoarthritis (OA).
According to the trend of the aging society in China, patients with osteoarthritis continue to grow. Osteoarthritis is the most common arthritis among Middle-aged and elderly people The prevalence rate of middle-aged people and the elderly over 60 is up to 50%, the prevalence rate of people over 75 is up to 80%, and the disability rate is up to 53%.
- 150 million people suffer from Osteoarthritis in great China.
Currently, osteoarthritis treatment methods in China generally adopt non-pharmacological treatment methods, drug treatment, intra-articular injection treatment and surgical treatment. More common treatments for non-surgical osteoarthritis include nonsteroidal anti-inflammatory drugs. Long-term use can easily cause adverse effects on the gastrointestinal tract and kidneys; Hyaluronic sodium injection can only relieve short-term symptoms and requires frequent injections. There are different problems with these treatments. “
RegenoGel osteoarthritis injection gel is made entirely of natural compatible materials. It has many benefits such as promoting regenerative healing, with no side effects and curative effect over time. It can effectively solve the pain of patients with moderate to severe osteoarthritis, improve range of motion and increase quality of life, currently there is no local product of the same strain on the market.
On January 19, relying on the policy benefits of the Cheng Halutz area, Boao Yilling led his presentation on RegenoGel, which brought good news to Chinese patients with osteoarthritis.
RegenoGel is suitable for all patients suffering from joint pain, osteoarthritis or other degenerative joint diseases (knees, thighs, ankles, shoulders, fingers, toes, etc.).
- There is currently no local product of the same type on the market;
- Regenogel can maintain the therapeutic effect for at least 12 months in patients with moderate to severe osteoarthritis (LeonidKandel, 2020);
- Regenogel is an effective long-term analgesic treatment of osteoarthritis;
- Significantly reduce joint pain, improve range of motion and improve quality of life;
- It is made entirely of natural biological ingredients to promote regeneration and healing with no side effects;
- Due to its unique material properties, it has high stability and lasting effect;
- It can reduce shock and disperse joint load, creating a micro-environment that contributes to regeneration and healing.
Attached is a link to the full article in Chinese: